CClinicalTrials.gg
Status unknownNCT02219763Updated Aug 19, 2014

The Effects of a Weight Management Program on Body Weight and Quality of Life

An observational study in Overweight and Obesity, sponsored by Massachusetts General Hospital. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-08-19.

Sponsored by Massachusetts General Hospital · Observational

The sponsor has not verified this record recently (last verified Jun 2014), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

Evaluate the impact of a 12-week behavioral weight management program on body weight and quality of life. We hypothesize that participants will lose body weight and see improved quality of life after program completion.

Read the detailed description

This study will evaluate weight change and quality of life among individuals after completion of a 12-week comprehensive group weight management program. Findings from this study will also help with program development and improvement within our center. The already established weight management program is called Healthy Habits for Life (HHL) and includes a total of 14 visits (one individual visit both before and after the 12 group sessions).

All patients who are enrolled in the Healthy Habits for Life group program at the Weight Center have an individual visit with a registered dietitian prior to beginning the group as part of standard care. At this visit the dietitian will obtain informed consent for participation in the research study and provide subjects consenting to participate in the study with the IWQOL-lite quality of life questionnaire.

After completion of the 12 HHL group sessions, all patients at the Weight Center have another individual visit with the dietitian to review weight and behavior changes since the initial evaluation. At this visit, subjects participating in the research study will again be provided with the IWQOL-lite questionnaire to fill out.

02

Conditions studied

  • Overweight
  • Obesity
03

In context

Overweight

3,670 studies on the registry are indexed under Overweight; 849 are open to participants now.

This study's planned enrollment of 50 is below the median of 150 across 436 observational studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.

Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults (over age 18) with a BMI ≥ 25 enrolled in the 12-week Healthy Habits for Life (HHL) group program from the MGH Weight Center will be recruited. Subjects will be recruited over a 5-month period.

Inclusion criteria

  • English speaking adults aged 18 or older
  • BMI ≥ 25
  • Enrolled in HHL program at the MGH Weight Center

Exclusion criteria

Exclusion Criteria:

  • Non-English speaking patients
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Weight Change

    The primary outcomes will be change in body weight comparing body weight at the start of the behavior change program and at the end. This includes weight at the initial individual visit, weights at each of the 12 group visits and body weight at the end of the group program.

    Time frame: Approximately 4 months after enrollment

Secondary outcomes

  1. Quality of Life

    Quality of life will be assessed with a validated questionnaire at the start of the group and after completion of the group program.

    Time frame: Approximately 4 months after enrollment

Other outcomes

  1. Blood laboratory values

    Labs collected include: Albumin, Alkaline Phosphatase, Total Bilirubin, Total Protein, ALT, AST, HbA1C, Lipids and Insulin. These labs will be collected at a patients first visit to the Weight Center and again after completion of the group program.

    Time frame: Approximately 4 months after enrollment

07

Study locations

1 of 1 sites recruiting
  • MGH Weight Center, Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
    • Sonja S Goedkoop, MSPH, RD · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02219763
Lead sponsor
Massachusetts General Hospital
Responsible party
Goedkoop, Sonja (Registered Dietitian, Massachusetts General Hospital) — Principal investigator
First posted
Aug 19, 2014
Start date
Jun 2014
Primary completion
Feb 2015 (estimated)
Completion
Feb 2015 (estimated)
Last update
Aug 19, 2014

Study contacts

Sonja S Goedkoop, MSPH, RD
Contact
sgoedkoop@partners.org
617-726-6126
Sonja S Goedkoop, MSPH, RD
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion